SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-18-019363
Filing Date
2018-03-21
Accepted
2018-03-21 17:16:03
Documents
1
Period of Report
2018-03-19

Document Format Files

Seq Description Document Type Size
1 4 a4.html 4  
1 4 a4.xml 4 3581
  Complete submission text file 0001104659-18-019363.txt   4961
Mailing Address 3 COLUMBUS CIRCLE, SUITE 1710 C/O ARALEZ PHARMACEUTICALS INC. NEW YORK NY 10019
Business Address
KOVEN ANDREW I (Reporting) CIK: 0001258673 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37691 | Film No.: 18705150

Mailing Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4
Business Address 7100 WEST CREDIT AVENUE, SUITE 101 MISSISSAUGA A6 L5N 0E4 905-876-1118
Aralez Pharmaceuticals Inc. (Issuer) CIK: 0001660719 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences